Literature DB >> 3125035

Epidermal growth factor, but not thyrotropin, stimulates the expression of c-fos and c-myc messenger ribonucleic acid in porcine thyroid follicle cells in primary culture.

N E Heldin1, B Westermark.   

Abstract

Previous studies have shown that TSH stimulates functional parameters in cultures of porcine follicle cells, but has no stimulatory effect on their growth. Epidermal growth factor (EGF), on the other hand, is a potent mitogen in such cells. The aim of the present investigation was to study the effect of EGF and TSH on the expression of proto-oncogene mRNA in porcine thyroid follicle cells. The addition of EGF caused a marked increase in the c-fos and c-myc mRNA levels. Stimulation of cells with 10 mU/ml TSH, however, failed to stimulate expression of the proto-oncogenes. The increase in c-fos mRNA caused by EGF was transient, with a maximum after 30 min. The c-myc transcript level increased after 30-60 min; the maximum level was at 90 min, and it decreased thereafter but remained at an elevated level throughout the 24 h of investigation. Half-maximal effects on proto-oncogene expression were obtained using 0.5-1 ng (c-fos) and 0.2-0.5 ng (c-myc) EGF/ml. Our data clearly demonstrate that increased expression of c-fos and c-myc mRNA is an early event in the prereplicative phase of EGF-stimulated porcine thyroid follicle cells. Since c-fos and c-myc expression may be necessary events in the prereplicative phase, the lack of effect of TSH on these functions may be closely related to its inability in stimulating the growth of porcine thyrocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125035     DOI: 10.1210/endo-122-3-1042

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies.

Authors:  Marc-André Fortin; Alexei V Salnikov; Marika Nestor; Nils-Erik Heldin; Kristofer Rubin; Hans Lundqvist
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-03       Impact factor: 9.236

2.  Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases.

Authors:  A C Colige; C A Lambert; B V Nusgens; C M Lapière
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

3.  Stimulation of proliferation and inhibition of function of xenotransplanted human thyroid tissue by epidermal growth factor.

Authors:  R Paschke; T Eck; J Herfurth; K H Usadel
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

4.  Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues.

Authors:  Q Y Duh; A E Siperstein; R A Miller; J J Sancho; M J Demeure; O H Clark
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

5.  Growth regulation of rabbit gastric epithelial cells and protooncogene expression.

Authors:  K Yoshiura; S Ota; A Terano; M Takahashi; Y Hata; T Kawabe; H Mutoh; H Hiraishi; R Nakata; K Okano
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

6.  Transplantable rat thyroid cancer cell line FRTC transformed with muramyl dipeptide.

Authors:  M Iitaka; N Fukasawa; S Kitahama; S Miura; Y Kawakami; H Sato; S Sugano; J Ishii; S Katayama
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5.

Authors:  C J van der Kallen; J H Coes; J P van Grafhorst; E M Schuuring; F A Ossendorp; J H Thijssen; M A Blankenstein; T W de Bruin
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture.

Authors:  J D Bergström; A Hermansson; T Diaz de Ståhl; N E Heldin
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.